Montreal, QC, Canada - June 6, 2014, Montreal, QC, Canada - Atrium Innovations Inc., a dietary supplements company, announced that Peter Luther, former president of Johnson & Johnson Consumer Healthcare, has been named president and CEO of Atrium, effective at the end of June.
Article continues below
Mr. Luther has 25 years of experience in the consumer packaged goods and healthcare industries. Since 1987, he has worked for Johnson & Johnson and has served as President of several of the company's large divisions over the past 10+ years. His most recent role was President of the Consumer Healthcare business.
Prior to his role as President of Johnson & Johnson Consumer Healthcare, Mr. Luther served as President of Johnson & Johnson's McNeil Consumer Healthcare with responsibility for such brands as Tylenol, Motrin, Zyrtec and Benadryl.
Previous roles included President of Johnson & Johnson Beauty Care with brands such as Neutrogena, Aveeno, Clean & Clear and Lubriderm and President of LifeScan, Inc., a manufacturer and marketer of glucose monitoring systems under the One Touch brand.
Mr. Luther received his Masters of Management from the Northwestern University Kellogg Graduate School of Management, and his BA from Kenyon College. He succeeds Pierre Fitzgibbon, who will leave the Company by mutual agreement with the Board of Directors.
The Company also announced that Jacques Bougie, former President and CEO of Alcan Inc., W. Brian Edwards, founder and former CEO of BCE Emergis, and Mr. Luther will join Atrium's Board of Directors. Mr. Bougie will serve as Chairman of the Board and be based in Montreal, Quebec.
Mr. Bougie was the President and CEO of Alcan Inc., a Quebec-based global aluminium producer and packaging products supplier, from 1993 to 2001. In this role, he spearheaded the greatest expansion in the company's history through its acquisition of AluSuisse in 2000 and laid the groundwork for the acquisition of the French group Pechiney in 2004.
Before serving as CEO, he was President and COO of Alcan from 1989 to 1993. Over the past 25 years, Mr. Bougie has served on the boards of Royal Bank of Canada, Bell Canada, BCE Mobile Communications, Nova Chemicals, Rona, Novelis, and AbitibiBowater and currently sits on the boards of McCain Foods, CSL Group and SNC-Lavalin Group. He currently chairs the Advisory Board of the Montreal Neurological Institute and Hospital and serves on the Board of Directors of a number of foundations. ■